Reaction
Injection Site Plaque reporting signals
As of the last recalculation, Injection Site Plaque appears in 204 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is CABOTEGRAVIR (PRR 51.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cabotegravir | 4 | 51.5 | 51.6 |
| Ixekizumab | 15 | 44.6 | 44.6 |
| Fremanezumab-Vfrm | 3 | 27.0 | 27.1 |